Mendeleev Commun., 2013, 23, 193–195
C(11)
lengths in the 2,3-(dimethyl)butadiene ligand and the Rh–C(78M)
C(12)
C(10)
C(9)
bond length in the cyclooctene ligand [C(12M), C(34M) and
C(78M) are the midpoints of the double bonds in these ligands]
are significantly different being 1.984(1), 1.998(1) and 2.147(1)
Å, respectively. To the best of our knowledge, the only precedent
of crystallographically characterized dimeric di-m-chloro-bridged
five-coordinate Rhi complexes with a comparable molecular
architecture is [(h2,k1-C10H8NBoc)(CO)RhCl]2 (where C10H8NBoc
is N-Boc-azabenzonorbornadiene).4
C(13)
C(14)
C(8)
C(7)
Cl(1A)
Rh(1A)
Rh(1)
Cl(1)
C(1)
C(3)
C(4)
C(2)
Mixed-ligand complexes 5 and 6 are key intermediates in
the formation of agostic closo-(p-allyl)rhodacarboranes species
of these series. It was found that both 5 and 6 react with 1b in
C6H6 at room temperature to give acyclic (p-allyl)-closo-rhoda-
carboranes: [3-{(1-3-h3)-C5H9}-1,2-Me2-closo-3,1,2-RhC2B9H9]
7a,b (two isomers) and [3-{(1-3-h3)-C6H11}-1,2-Me2-closo-3,1,2-
RhC2B9H9] 8, respectively, in high yields. The structures of
complexes 7a,b and 8 were deduced by a comparison of their
1H NMR spectra with those of authentic samples which have been
prepared earlier via the one-pot method1 outlined in Scheme 1.
In addition, the reaction of 6 with 1d (R = Me, R' = Ph) was found
to afford the new p-allyl derivative [3-{(1-3-h3)-C6H11}-1-Me-
2-Ph-closo-3,1,2-RhC2B9H9] isolated in 56% yield (total content)
as an inseparable mixture of two diastereomers 9a,b (Scheme 3).
These isomeric complexes were characterized by elemental analysis
and multinuclear NMR spectroscopy, although the precise stereo-
chemistry of 9a,b cannot be assigned based on these data only.§
C(5)
C(6)
Figure 1 ORTEP representation of the molecular structure of complex 6
with thermal ellipsoids drawn at a 50% probability level. Hydrogen atoms are
omitted for clarity. Selected interatomic distances (Å) and bond angles (°):
Rh(1)–Cl(1) 2.5001(3), Rh(1)–Cl(1A) 2.5098(3), Rh(1)–C(7) 2.250(1),
Rh(1)–C(8) 2.260(1), Rh(1)–C(1) 2.063(1), Rh(1)–C(2) 2.159(1), Rh(1)–C(3)
2.164(1), Rh(1)–C(4) 2.085(1), C(1)–C(2) 1.447(2), C(2)–C(3) 1.417(2),
C(3)–C(4) 1.445(2), C(7)–C(8) 1.381(2), C(8)–C(9) 1.510(2), C(7)–C(14)
1.504(2), Rh(1)···Rh(1A) 3.6392(2); Cl(1)–Rh(1)–Cl(1A) 86.83(1), Rh(1)–
Cl(1)–Rh(1A) 93.17(1).
centre, thus having a centrosymmetric structure. Two crystallo-
graphically equivalent [(h2-C8H14)(h4-C6H10)RhCl] fragments
in 6 are linked together by two symmetrical m-chloro bridges
[Rh–Cl, 2.5001(3) and 2.5098(3) Å], while the butadiene and
cyclooctene ligands are in trans position to each other. Each
rhodium atom in 6 is bound to one 2,3-dimethylbuta-1,3-diene
ligand, which acts as an h4-coordinating ligand, and one weakly
coordinated cyclooctene ligand. Of particular interest is the
coordination geometry of the rhodium atoms, as determined in
structure 6. Assuming that each m-chloro ligand occupies only
one coordination site and the Rh–Rh bond in 6 is excluded
[Rh···Rh, 3.6392(2) Å], the rhodium atoms in this complex have
a coordination number of five. The Rh–(m-Cl2)–Rh four-mem-
bered ring is planar with the Rh(m-Cl)2 angle of 86.83(1)°.
Although the cyclooctene ligand in 6 is located rather far from
the rhodium centre, it still remains coordinated to each of the
rhodium atoms. Note that the Rh–C(12M) and Rh–C(34M) bond
Hsyn
Hanti
Hsyn
Hanti
CH2
Me
Me
CH2
H
H
Ph
Rh
Rh
H
6
Me
Me
K+
+
Me
Ph
Me
Me
Ph
C6H6,
20 °C
1d
9a
9b
Scheme 3
§
Diastereomeric complexes [3-{(1-3-h3)-C6H11}-1-Me-2-Ph-closo-3,1,2-
RhC2B9H9] 9a,b. To a solution of 6 (65 mg, 0.1 mmol) in 4 ml of degassed
benzene, K salt 1d7 (66 mg, 0.25 mmol) was added in one portion as a
solid. After 2 h of vigorous stirring, the resulting red solution was treated
by column chromatography on silica gel, eluting a colored fraction with
a mixture of CH2Cl2–hexane (1:2). After the removal of the solvent in
vacuo and recrystallization of the residue from a mixture of CH2Cl2–
hexane, 43 mg (53%) of isomeric complexes 9a,b were obtained as a light
red amorphous solid.
For 5: yellow microcrystals, 51% yield. 1H NMR (400.13 MHz, CD2Cl2)
d: 5.50 (m, 4H, 1,2-CH, COE), 4.97 [br.t, 2H, H(3), Jt 7.3 Hz], 2.39
[br.s, 2H, H(1)syn], 2.35 [d, 2H, H(4)syn, Jvic 5.4 Hz], 2.16 (br.s, 8H,
3,8-CH2, COE), 2.06 (s, 6H, Me), 1.54 (br.s, 16H, 4,5,6,7-CH2, COE),
0.48 [br.s, 2H, H(1)anti], 0.43 [d, 2H, H(4)anti, Jvic 9.0 Hz]. 13C{1H} NMR
(100.61 MHz, CD2Cl2) d: 122.0 (1,2-CH, COE), 101.4 [C(2)], 85.6 [C(3)],
39.5 [C(1)], 36.9 [C(4)], 30.5, 27.1 (4,5,6,7-CH2, COE), 27.0 (3,8-CH2,
COE), 22.0 (Me). Found (%): C, 48.91; H, 6.88; Cl, 11.33. Calc. for
C26H44Cl2Rh2 (%): C, 49.31; H, 7.00; Cl, 11.20.
For 9a,b: IR (KBr, n/cm–1): 2548 (nBH). 1H NMR (600.22 MHz,
CD2Cl2; 9a:9b = 1:2.3*) d: 7.84* (dd, 2H, Ph, J1 7.7 Hz, J2 1.9 Hz), 7.51
For 6: yellow microcrystals, 65% yield. 1H NMR (400.13 MHz, CD2Cl2)
d: 5.52 (m, 4H, 1,2-CH, COE), 2.21 [br.s, 4H, H(1,4)syn], 2.15 (br.s, 8H,
3,8-CH2, COE), 1.97 [s, 12H, 2,3-Me], 1.54 (br.s, 16H, 4,5,6,7-CH2, COE),
0.24 [br.s, 4H, H(1,4)anti]. 13C{1H} NMR (150.93 MHz, CD2Cl2) d: 121.2
(1,2-CH, COE), 96.1 [C(2,3)], 37.5 [C(1,4)], 30.5, 27.1 (4,5,6,7-CH2,
COE), 27.0 (3,8-CH2, COE), 18.8 (2,3-Me). Found (%): C, 49.35; H, 6.85;
Cl, 11.56. Calc. for C28H48Cl2Rh2 (%): C, 50.83; H, 7.26; Cl, 10.74.
(d, 2H, Ph, J 7.4 Hz), 7.36–7.26 (m, 6H, Ph, Ph*), 4.25* [d, 1H, H(3')syn,
Jgem 1.8 Hz], 3.98 [d, 1H, H(3')syn, Jgem 2.2 Hz], 2.86 (s, 3H, Mecarb), 2.63
[br.s, 1H, H(3')anti], 2.55* [br.s, 1H, H(3')anti], 2.39* (s, 3H, Mecarb),
2.16* (s, 3H, Mesyn), 2.00 (s, 3H, Mesyn), 1.70* (d, 3H, 2'-Me, J 2.2 Hz),
1.67 (d, 3H, 2'-Me, J 2.0 Hz), 0.00* [s, 3H, Meanti (agost.)], –0.33 [s, 3H,
Meanti (agost.)]. 13C{1H} NMR (150.93 MHz, CD2Cl2, J
Rh) d: 147.0,
13C,103
144.1, 129.8, 129.5, 129.2, 128.9, 128.4, 127.4 (CAr, C* ), 117.9 [d,
Ar
‡
Crystal data for 6: C28H48Cl2Rh2, M = 661.38, orthorhombic, space
C(2'), J 5.4 Hz], 117.9* [d, C(2'), J 5.5 Hz], 116.1, 111.4 (Ccarb), 109.9*,
104.3* (Ccarb), 97.9* [d, C(1'), J 5.8 Hz], 96.9 [d, C(1'), J 5.9 Hz], 61.2
[d, C(3'), J 8.9 Hz], 60.3* [d, C(3'), J 9.3 Hz], 36.7 (Mecarb), 32.6*
group Pbca, a = 10.5900(4), b = 14.2438(5) and c = 18.1388(6) Å, V =
= 2736.1(2)Å3, dcalc = 1.606 g cm–3, Z = 4, MoKa radiation (l = 0.71073Å),
m = 1.416 mm–1, T = 100(2) K, 2qmax = 60°, R1 = 0.0169 for 3702 reflec-
tions with I > 2s(I), and wR2 = 0.0395 for all 3965 unique reflections
(Rint = 0.0296). The SHELXTL program package5 was used for the calcu-
lations.
CCDC 921336 contains the supplementary crystallographic data for
this paper. These data can be obtained free of charge from The Cambridge
For details, see ‘Notice to Authors’, Mendeleev Commun., Issue 1, 2013.
(Mecarb), 21.5* (Mesyn), 20.4* (2'-Me, 2'-Me*), 20.2 [Me* (agost.), Mesyn],
anti
20.1 [Meanti (agost.)]. 11B NMR (193 MHz, CD2Cl2, J11B,1H) d: 20.1 (d,
J 147 Hz), 14.5 (d, J 125 Hz), 13.7 (d, J 147 Hz), 10.0 (d, J 144 Hz), 4.1 (d,
J 140 Hz), 3.3 (d, J 166 Hz), 2.4 (d, J 171 Hz), –1.3 (d, J 166 Hz), –2.2
(d, J 175 Hz), –3.1 (d, J 160 Hz), –3.9 (d, J 152 Hz), –4.7 (d, J 160 Hz), –5.6
(d, J 196 Hz), –6.5 (d, J 140 Hz), –18.7 (d, J 152 Hz), –20.0 (d, J 153 Hz).
Found (%): C, 43.71; H, 7.20; B, 22.83. Calc. for C15H28B9Rh (%): C, 44.09;
H, 6.91; B, 23.81.
– 194 –